Kiffik Biomedical

Series-A
kiffik.com Biotech & Healthcare
Total Funding $20M
Latest Round $20M Series-A
Last Announced Dec 30, 2025
Investors Undisclosed
Decision Makers Profile Active

About Kiffik Biomedical

Where BiologyFirst Appears Biology is often measured after dilution, degradation, and systemic clearance. KIFFIK enables direct access to Interstitial Fluid (ISF) — the molecular environment surrounding living cells where biology becomes visible earlier.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website kiffik.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $20,000,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Kiffik Biomedical.

Funding History

1 Round
Series-A equity · Dec 30, 2025

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts